Litcius/Paper detail

Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis

Juan P. Rodrigo, Mario Sánchez‐Canteli, Fernando López, Gregory T. Wolf, Juan C. Hernandez‐Prera, Michelle D. Williams, Stefan M. Willems, Alessandro Franchi, Andrés Coca‐Pelaz, Alfio Ferlito

2021Biomedicines52 citationsDOIOpen Access PDF

Abstract

The presence of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment has been demonstrated to be of prognostic value in various cancers. In this systematic review and meta-analysis, we investigated the prognostic value of TIL in laryngeal squamous cell carcinoma (LSCC). We performed a systematic search in PubMed for publications that investigated the prognostic value of TIL in LSCC. A meta-analysis was performed including all studies assessing the association between TIL counts in hematoxylin-eosin (HE)-stained sections, for CD8+ and/or CD3+/CD4+ TIL and overall survival (OS) or disease-free survival (DFS). The pooled meta-analysis showed a favorable prognostic role for stromal TIL in HE sections for OS (HR 0.57, 95% CI 0.36–0.91, p = 0.02), and for DFS (HR 0.56, 95% CI 0.34–0.94, p = 0.03). High CD8+ TIL were associated with a prolonged OS (HR 0.62, 95% CI 0.4–0.97, p = 0.04) and DFS (HR 0.73, 95% CI 0.34–0.94, p = 0.002). High CD3+/CD4+ TIL demonstrated improved OS (HR 0.32, 95% CI 0.16–0.9, p = 0.03) and DFS (HR 0.23, 95% CI 0.10–0.53, p = 0.0005). This meta-analysis confirmed the favorable prognostic significance of TIL in LSCC. High stromal TIL evaluated in HE sections and intra-tumoral and stromal CD3+, CD4+ and/or CD8+ TIL might predict a better clinical outcome.

Topics & Concepts

Meta-analysisTumor-infiltrating lymphocytesMedicineH&E stainInternal medicineStromal cellOncologyCD8Tumor microenvironmentSubgroup analysisPathologyImmunohistochemistryImmunotherapyImmune systemCancerImmunologyCancer Immunotherapy and BiomarkersImmune cells in cancerInflammatory Biomarkers in Disease Prognosis